Enteroscopic evaluation of the gastrointestinal tract in symptomatic patients with hereditary hemorrhagic telangiectasia

被引:3
作者
Proctor, DD
Henderson, KJ
Dziura, JD
Longacre, AV
White, RI
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Gen Clin Res Ctr, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA
关键词
hereditary hemorrhagic telangiectasia; GI bleeding; arteriovenous malformations; anemia; enteroscopy;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Hereditary hemorrhagic telangiectasia is an autosomal dominant disease in which 25% to 30% of patients will develop gastrointestinal bleeding from telangiectases. The extent of telangiectases has not been previously evaluated. This cross-sectional study compared the presence, number, and size of telangiectases in the stomach and duodenum to those in the jejunum using enteroscopy. Methods: At the Yale University Vascular Malformation Center, 30 consecutive, symptomatic adult patients with hereditary hemorrhagic telangiectasia were evaluated using a 220-cm-length enteroscope. The number and size of the telangiectases were documented in the esophagus, proximal and distal stomach, four parts of the duodenum, and every 20 cm in the jejunum. The indication for the procedure was recorded as anemia, gastrointestinal bleeding, or anemia out of proportion to epistaxis. Results: The results of 27 patients were analyzed. A total of 89% of patients had telangiectases in the first 60 cm of the jejunum. In individual patients, there was a strong correlation between the number of telangiectases in the stomach/duodenum when compared with the jejunum. In group analysis, the median number of telangiectases in the stomach and duodenum was significantly higher than in the jejunum (13 vs. 3; Wilcoxon signed rank test, P = 0.001). The presence of large ( greater than or equal to 5 mm) telangiectases in the stomach/duodenum did not necessarily indicate that there would be large telangiectases in the jejunum. Conclusions: The presence and number of stomach and duodenal telangiectases correlated with the presence and number of jejunal ones. However, the occurrence of large proximal telangiectases was not associated with large distal ones.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 50 条
[31]   Imaging of Hereditary Hemorrhagic Telangiectasia [J].
Marie-France Carette ;
Cosmina Nedelcu ;
Marc Tassart ;
Jean-Didier Grange ;
Marie Wislez ;
Antoine Khalil .
CardioVascular and Interventional Radiology, 2009, 32 :745-757
[32]   A Case of Hereditary Hemorrhagic Telangiectasia [J].
Lee, Ha Eun ;
Sagong, Chan ;
Yeo, Kwang Yeoll ;
Ko, Joo Yeon ;
Kim, Joung Soo ;
Yu, Hee Joon .
ANNALS OF DERMATOLOGY, 2009, 21 (02) :206-208
[33]   Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia [J].
Buscarini, Elisabetta ;
Maria Botella, Luisa ;
Geisthoff, Urban ;
Kjeldsen, Anette D. ;
Mager, Hans Jurgen ;
Pagella, Fabio ;
Suppressa, Patrizia ;
Zarrabeitia, Roberto ;
Dupuis-Girod, Sophie ;
Shovlin, Claire L. .
ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
[34]   Neuroimaging of hereditary hemorrhagic telangiectasia [J].
Bracard, S ;
Schmitt, E ;
Kremer, S ;
Anxionnat, R ;
Picard, L .
JOURNAL OF NEURORADIOLOGY, 2005, 32 (03) :168-173
[35]   Imaging of Hereditary Hemorrhagic Telangiectasia [J].
Carette, Marie-France ;
Nedelcu, Cosmina ;
Tassart, Marc ;
Grange, Jean-Didier ;
Wislez, Marie ;
Khalil, Antoine .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 32 (04) :745-757
[36]   Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia [J].
Jorgensen, Gita ;
Lange, Bibi ;
Wanscher, Jens Hojberg ;
Kjeldsen, Anette Drohse .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (12) :1765-1770
[37]   Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia [J].
Cottin, V ;
Plauchu, H ;
Bayle, JY ;
Barthelet, M ;
Revel, D ;
Cordier, JF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (09) :994-1000
[38]   Hereditary Hemorrhagic Telangiectasia/Avastin [J].
Davidson, Terence M. ;
Olitsky, Scott E. ;
Wei, Julie L. .
LARYNGOSCOPE, 2010, 120 (02) :432-435
[39]   Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia [J].
Elisabetta Buscarini ;
Luisa Maria Botella ;
Urban Geisthoff ;
Anette D. Kjeldsen ;
Hans Jurgen Mager ;
Fabio Pagella ;
Patrizia Suppressa ;
Roberto Zarrabeitia ;
Sophie Dupuis-Girod ;
Claire L. Shovlin .
Orphanet Journal of Rare Diseases, 14
[40]   Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation [J].
Edwards, Christine Priscilla ;
Shehata, Nadine ;
Faughnan, Marie E. .
ANNALS OF HEMATOLOGY, 2012, 91 (12) :1959-1968